Director, Alliance Management

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Alliance Management will serve as a key liaison between RevMed and its strategic partners, ensuring the success of collaborations across research and development. This role requires a dynamic leader with strong relationship management skills and the ability to drive alignment between internal teams and external stakeholders to achieve shared objectives. Strategic Partnership Management: Oversee a variety of strategic alliances with industry and academic partners to optimize collaboration effectiveness and achieve goals for the alliance. Serve as the primary RevMed point of contact for these partners. Stakeholder Engagement: Facilitate regular communication between internal teams and external partners through joint governance committees, steering committees, and operational working groups. Project Coordination: Ensure integration of alliance-related activities across R&D, clinical operations, regulatory affairs, and business development functions. Issue Resolution and Risk Mitigation: Identify potential risks for active and potential partnerships and proactively develop mitigation strategies. Contract and Agreement Oversight: Monitor partnership agreements to ensure contractual obligations are met. Proactively identify potential issues that may arise between the agreement and operationalizing the alliance. Experience negotiating and interpreting R&D related contracts including licenses, quality, and pharmacovigilance agreements. Cross-Functional Collaboration: Act as a bridge between scientific, clinical, and business teams to drive alignment on strategic objectives. Required Skills, Experience and Education: Bachelor’s (BS) degree. 10+ years of experience in biotechnology, pharmaceutical, or life sciences, with at least 5 years in alliance management or business development. Experience with leading and managing cross-border transactions, including in-licenses and out-licenses for clinical stage drug candidates. Understanding drug development, clinical trial processes, and regulatory requirements for major markets. Proven track record of managing a variety of partnerships across different stages of drug discovery, development, and commercialization. Outstanding verbal and written communication skills to summarize complex information; effectively interacts and influences across functional areas, project teams, and key external stakeholders. Excellent negotiation and problem-solving skills. Innovative, proactive, and collaborative team-player with high energy to keep pace with our growing and evolving company environment. Preferred Skills: Advanced degree (Ph.D., MBA, M.S., or equivalent) in life science